Search results
Showing 3301 to 3315 of 7683 results
Data on the recommendations made by our technology appraisal programme. Includes information on the number of positive recommendations we've made.
Data on the cancer recommendations made by our technology appraisal programme. Includes information on the number of positive recommendations we've made.
We are evolving to make sure we’re meeting the changing needs of the health and care system
Information about providers of medical and healthcare related content under the NICE Electronic and Print Content Framework Agreement
Where you can find more information about how we operate
NICE research projects and partners.
We estimate the costs or savings (budget impact) associated with technologies and guidelines so you can plan for and implement guidance.
Our tool to help you plan for and implement NICE guidance. View upcoming guidance and understand the impact of guidance on your resources.
Should I stop my benzodiazepine or z-drug? Patient decision aid: summary Do not stop taking your benzodiazepine or z-drug suddenly What are...
Diabetes: blood pressure (without moderate or severe frailty)
This indicator has been updated and replaced by NICE indicator 249.
Atrial fibrillation: pulse rhythm assessment in people at risk
This indicator has been withdrawn following National Screening Committee recommendations and ongoing research.
This indicator has been withdrawn following discussions with the National Screening Committee.
A new model for evaluating and purchasing antimicrobials in the UK
Antimicrobial resistance (AMR) is an urgent global challenge. It causes around 700,000 deaths each year globally . That number is predicted to rise to
Technology appraisal submission templates and supporting documents
On this page, you'll find all the templates and supporting documents you need to make a technology appraisals submission. These templates have been...
This indicator covers the proportion of children and young people with diabetes who have had their glycated haemoglobin A1c (HbA1c) monitored in the previous 12 months. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as CCG67